Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.6759
-0.0141 (-2.04%)
May 5, 2026, 11:45 AM EDT - Market open
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $32.85 million as of May 5, 2026. Its market cap has decreased by -20.27% in one year.
Market Cap
32.85M
Enterprise Value
-14.08M
1-Year Change
-20.27%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $32.85M, a decrease of -92.54%. That is a compound annual growth rate of -40.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 33.53M | 9.05% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 36.27M |
| Grace Therapeutics | 36.21M |
| Sensei Biotherapeutics | 36.13M |
| Apollomics | 35.62M |
| Actinium Pharmaceuticals | 35.23M |
| Boundless Bio | 35.18M |
| CervoMed | 34.35M |
| Daré Bioscience | 34.07M |